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Introduction 
Type 1 diabetes mellitus (DM) is a systemic disease 
which causes a number of complications which reduce the 
quality of life of the affected individuals. Gingivitis and pe-
riodontitis are local inflamatory diseases of the supporting 
tooth structures (periodontium) which can have an influence 
on other organs and organic systems. The Expert Group Re-
port on Diagnosis and Classification of Diabetes 1 included 
periodontitis as one of the pathological conditions which of-
ten occur in adults with DM. However, it has not yet been 
defined whether patients with DM are likely to develop pe-
riodontitis, or if periodontitis leads to the exacerbation of 
DM. Although, there are many data indicating the correlation 
between periodontitis and type 1 DM in children and adults, 
the influence of the level of glycaemic control on the condi-
tion of periodontium is still not entirely clear. Additionally, 
the quantitative status of immunological markers in saliva in 
these two diseases is unknown. 
The aim of this paper was to present clinical studies 
dealing with the biochemical processes in saliva and other 
bodily fluids, which could elucidate the relationship between 
gingivitis and periodontitis, on the one hand, and type 1 DM, 
on the other. 
The literature data on the correlation between gingivi-
tis/periodontitis and type 1 DM were collected in the period 
from 1968 to September 2011 using the PubMed and Med-
line data bases and 59 studies were selected for this paper. 
The analysis encompassed original papers, review articles 
and scientific and expert meetings reports. All selected stud-
ies were published in English language. The analysis did not 
include: case reports, letters to the editors, short announce-
ments, studies with inadequate methodology and incomplete 
or unrelated articles. The following key words were used for 
the electronic search in the MeSH browser: periodontitis, 
gingivitis, type 1 diabetes mellitus, cytokines, interleukin-8 
and saliva. 
A summary table was created with data including the 
authors' name, the year of publication of the study, the dura-
tion of type 1 DM, the monitored biochemical and clinical 
parameters and the conclusion based on the examined arti-
cles (Addendum 1). 
Type 1 diabetes mellitus 
Type 1 DM is primarily found in children and adoles-
cents and makes up 5–10% of the total number of patients 
with both types of diabetes 2. The pathological basis of type 
1 DM is the autoimmune destruction of pancreatic islets' β-
cells resulting in a marked or complete loss of insuline secre-
tion resulting in hyperglycemia. Various types of molecular 
markers of autoimmune β-cells destruction can be detected in 
85–90% of patients with hyperglycemia 2. Some of them, 
such as autoantibodies against insulin, glutamic acid decar-
boxylase and tyrosine phosphatases, are used for the diagno-
sis and risk assessment of developing type 1 DM 3. Compli-
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cations of type 1 DM are retinopathy with a possible loss of 
sight, nephropathy which leads to renal failure, peripheral 
neuropathy with a risk of ulcerations and amputation of the 
lower extremities and autonomic neuropathy causing gastro-
intestinal, genitourinary and cardiovascular diseases. Athero-
sclerosis, cardiovascular, peripheral arterial and cerebrovas-
cular diseases are more often present in patients with diabe-
tes mellitus 2. In addition to these, accompanying skin le-
sions were examined in children with type 1 DM 4. Further-
more, in 1993, periodontitis was identified as one of the clas-
sic complications of DM 5. An important indicator of general 
condition and possible diabetes complications is metabolic 
control, which is monitored through the blood glucose level 
(BGL) and glycosylated hemoglobin level (HbA1c). In 
healthy individuals, the proportion of HbA1c ranges between 
4% and 6% of total hemoglobin, while in the hyperglycaemic 
it can reach 15%. Since HbA1c remains stable for several 
months after the occurrence of hyperglycaemia, it serves as a 
marker of the severity of DM or the efficacy of metabolic 
control during a certain period of time. The treatment of DM 
is aimed at normalising the blood glucose levels and reduc-
ing the HbA1c level to less than 7.5% 6. 
Gingivitis and periodontitis 
Gingivitis and periodontitis are localised infections of 
the periodontium, which consists of the gingiva, the perio-
dontal membrane, the root cementum and the alveolar bone. 
Gingivitis is an inflammation which affects only the gingiva, 
whereas periodontitis is an inflammation of the deeper perio-
dontal tissues. Both diseases result from the interaction be-
tween periodontal pathogenic microorganisms and host tis-
sues. Periodontal pathogens consist the bulk of the soft (den-
tal biofilm) and solid (dental calculus) deposits on teeth. 
Dental biofilm is a colony of microorganisms which sponta-
neously and progressively accumulate on all solid surfaces in 
the mouth, primarely on teeth. Although this accumulation is 
spontaneous, many local factors can facilitate it. Gingivitis is 
initiated by the presence of periodontal pathogenic microor-
ganisms which cause the disease, but the host response to the 
infection is critical for disease progression. Various systemic 
factors can influence this response. The clinical course of the 
advanced periodontitis does not differ in relation to the type 
of periodontal bacteria which induce the immune-mediated 
destructive processes 7. When dental biofilm is present gin-
giva becomes red, enlarged, and bleeds easily when probed. 
Further expansion of the inflammatory process into the deep-
er periodontal tissues leads to the apical migration of the epi-
thelial attachment resulting in the periodontal pocket, which 
is a pathognomonic sign of periodontitis. Unless the process 
is arrested by treatment, it will lead to alveolar bone resorp-
tion, which ultimately causes tooth loss. It was previously 
thought that gingivitis, if left untreated, will progress into pe-
riodontitis. However, gingivitis and periodontitis are two dif-
ferent pathological entities and although periodontitis is pre-
ceded by gingivitis, not all cases of gingivitis will progress to 
periodontitis. So far, it is not completely clear why and how 
gingivitis progresses to periodontitis. 
Besides oral implications, periodontitis has an influence 
on systemic health. Systemic inflammation was more pro-
nounced in patients with periodontitis as detected by the in-
creased level of various serum inflammatory markers com-
pared to the healthy controls 8. Also, depending on the de-
gree of the host response during periodontits, various in-
flammatory biomarkers can be detected in samples of gingi-
val crevicular fluid and saliva. Some of these molecules can 
influence gene expression in individuals with genetic poly-
morphism with the tendency to develop periodontitis 9. The-
se molecules can be used as diagnostic markers and tests and 
methods of assessing the risk of periodontitis by measuring 
the level of biomarkers are constantly being improved. 
The correlation between diabetes mellitus and 
gingivitis/periodontitis 
Diabetes and gingivitis/periodontitis are widespread 
chronic diseases. Their pathogenetic mechanisms are be-
lieved to be interrelated and many authors have proposed the 
mechanisms to explain their correlation. These common 
mechanisms can be attributed to the following factors: micro 
vascular disease, changes in the composition of the gingival 
crevicular fluid, changes in collagen metabolism, altered host 
response, increased presence of periodontal pathogenic mi-
croorganisms, genetic predisposition and non-enzymatic gly-
cosylation. Generally, in order to confirm the relationship be-
tween DM and gingivitis/periodontitis biologically plausible 
mechanisms must exist underlying the pathological interac-
tions. These mechanisms are very similar to those of classic 
diabetic complications such as retinopathy, nephropathy, mi-
crovascular and macrovascular diseases and impaired wound 
healing. 
Many studies indicate a higher incidence and severity 
of gingivitis and periodontitis in children and adolescents 
with type 1 DM compared to healthy children. According to 
Cianciola et al. 10, severity and incidence of periodontal in-
volvement was statistically more prominent in patients with 
type 1 DM and accompanying periodontitis compared to 
non-diabetic individuals of that age. In support to the above 
data, the results of Lalla et al. 11 and Daković and Pavlović 12 
showed that gingival inflammation was significantly more 
common in children and adolescents with type 1 DM com-
pared to the systemically healthy subjects of the same age 
group. Jenkins and Papapanou 13 demonstrated that children 
with type 1 DM were in high risk of developing gingivitis, 
while the incidence of gingivitis in children and adolescents 
was almost double compared to adults. Some studies showed 
that severe forms of gingivitis were more frequent in chil-
dren with type 1 DM compared to healthy children 10, 14, 
whereas other studies did not find this difference 15. 
The available literature data on the exclusive influence 
of dental biofilm on the development of gingivitis in patients 
with type 1 DM are contraversial. In one study, the presence 
of gingivitis in children with type 1 DM was not related to 
higher dental biofilm accumulation, because a significant in-
crease in plaque index (PI) was not found in this popula-
tion 16. Contrary to this, another study showed a significant 
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correlation between the presence of dental biofilm and gingi-
vitis in children with type 1 DM compared to a healthy popu-
lation 13. In the research of Daković and Pavlović 12 the per-
centage of tooth sites with a gingival index (GI) higher than 
2 was 18.3% in children with type 1 DM compared to 9.7% 
in healthy children, which is almost twice as high and with a 
high statistical significance (p < 0.001). This is in accordance 
with most authors who examined GI in this category of pa-
tients 11, 14, 17, 18. Additionally, the percentage of tooth sites 
where PI score was higher than 2 was significantly higher in 
children with type 1 DM compared to healthy children 12, 
which was in accordance with most authors 11, 14, 16, 17. 
Daković and Pavlović 12 also investigated the relationship 
between gingival bleeding and dental biofilm (the number of 
bleeding tooth sites compared to the number of biofilm cov-
ered tooth sites). The multivariate logistic regression analysis 
showed that periodontitis was in a positive correlation with 
GI and, more importantly, with bleeding/dental biofilm 12. 
Additionally, the increase in the relationship between bleed-
ing and dental biofilm can identify the individuals inclined to 
develop periodontitis and be of great importance as a prog-
nostic indicator of potential periodontitis 19. 
Several studies showed a positive correlation between 
glucose level and gingival inflammation. Hyperglycemia in 
children with a newly diagnosed DM was associated with a 
more severe form of gingival bleeding which is reduced by 
the improvement in glucose metabolism after the insulin 
therapy training. Children with poor metabolic control (aver-
age HbA1 = 15%) had a higher level of gingival bleeding 
compared to those with good or mild metabolic control 20. 
These children had a higher risk of developing a more severe 
form of periodontitis 12, 17, 21. Such findings in patients with 
type 1 DM can be explained by the fact that the excessive 
blood glucose, which enters the oral cavity through saliva 
and gingival crevicular fluid, soaks the biofilm and causes an 
increase in total biofilm accumulation. In children with poor 
metabolic control this mechanism can overwhealm the host 
defence against the dental biofilm and increase the risk of 
developing gingivitis. However, the reduction of hypergly-
cemia did not affect the clinical attachment level (CAL), 
probing pocket depth (PPD), gingival bleeding index (GBI) 
and PI 12. This can be explained by the fact that the im-
provement of glycaemic control in patients with type 1 DM 
can improve the periodontal parameters, but only if the pa-
tients adhere to proper oral hygiene measures. 
It was found that pathological morphologic characteris-
tics of capillaries in the gingiva and labial mucosa in patients 
with DM were more prominent compared to the healthy in-
dividuals 22. Long-term hyperglycemia causes thinning of the 
basal membrane of vessel walls lining leading to the deterio-
ration of tissue nourishment and leukocyte migration. This 
contributed to the concept of importance of the morphologi-
cal and functional diabetic microvascular changes in the pe-
riodontium in patients with type 1 DM. 
The values of clinical periodontal parameters in the 
subjects with type 1 DM 12 showed a better condition of their 
periodontium compared to the values of other authors in the 
same category 11, 14, 17. However, the incidence of periodonti-
tis was statistically higher in children suffering from DM, 
compared to healthy children. The ratio of periodontitis in 
healthy children was 7.9%, while in children with type 1 DM 
periodontitis was three times more common, i.e. 21.5%. Ad-
ditionaly, there was a higher presence of a more severe form 
of periodontits, albeit statistically insignificant 12. The analy-
sis of the effects of type 1 DM on the destruction of perio-
dontal tissues showed some interesting results. Comparing 
CAL in diseased and healthy children a stastistically signifi-
cant difference was not found, but there was a significant dif-
ference in these two groups when the number of teeth and 
the number of tooth sites affected by periodontitis were 
compared 12. Type 1 DM was significantly correlated with 
the level of destruction of the periodontium regardless of the 
cut-off clinical parameter values used to define periodonti-
tis 12. This information, as well as the results of other au-
thors 17, show that type 1 DM is a significant systemic factor 
which influences the development of periodontitis. 
Numerous studies show that patients with DM and pe-
riodontitis have a higher risk of deterioration of glycaemic 
control over time compared to patients with DM alone 23. 
This is in accordance with the results of other authors who 
have found that children with type 1 DM and poor metabolic 
control had a higher risk of developing a more severe form 
of periodontitis 12, 17, 21. The influence of periodontal infec-
tion on the glycaemic control can be explained in several 
ways. The systemic inflammation following systemic infec-
tions, stimulates insulin resistance and affects the dynamics 
of glucose in the body 24. There is evidence that periodonti-
tis, although a local disease, can stimulate or lead to a con-
tinuous increase in the systemic chronic inflammatory condi-
tion, reflected in the elevated level of serum C-reactive pro-
tein (CRP), interleukin-6 (IL-6) and fibrinogen, especially in 
those harbouring Gram-negative periodontal pathogens 
(Porphyromonas gingivalis, Tannerella forsythensis and 
Prevotella intermedia) 5. Bacteremia and endotoxemia, a re-
sult of the systemic dissemination of periodontal pathogens 
or their products, induce a systemic imflammatory disorder 
with an increase in the levels of serum inflammatory mark-
ers 25. One study showed that the level of endotoxin in blood 
was five times higher in patients with periodontitis compared 
to healthy individuals 26. The presence of periodontitis en-
ables oral microorganisms and their products to reach sys-
temic circulation 27. 
Conversely, the mechanisms influencing the develop-
ment of other complications of type 1 DM can also affect the 
pathogenesis of periodontitis 28. Some studies examining the 
correlation between type 1 DM and periodontitis are shown 
in Addendum 1. The resuts of these studies are difficult to 
compare due to a variaty of clinical and laboratory protocols 
used. Besides, there is a certain number of studies which are 
not shown in Table 1 due to the obsolescence or inadequate 
presentation of clinical parameters. Namely, the parameters 
of gingival and periodontal health have recently been exam-
ined in more detail, whereas the percentage of the affected 
sites and the ratio between bleeding and dental biofilm were 
also examined in adition to GI and PI. Furthermore, special 
attention is paid to the parameters of periodontal destruction, 
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particularly to CAL, so that the term 'periodontal destruction' 
implies that there is at least one site with epithelial attach-
ment loss larger than 1.5 mm (or 2 mm depending on the au-
thor) on two non-adjacent teeth. The duration of DM is an 
important risk factor for developing periodontitis. In young 
patients with type 1 DM periodontal tissue destruction starts 
relatively early, in pre-adolescent and adolescent period, de-
pending on the duration of the underlying disease 12. Loss of 
epithelial attachment was more pronounced in patients suf-
fering from type 1 DM longer than 10 years 29. On the same 
lines, the results of Lalla et al. 11 are important since they 
show that type 1 DM have a strong role in the development 
of periodontitis in early childhood. In contrast, previous stud-
ies showed that there were no significant differences in the 
values of periodontal parameters in children with type 1 DM, 
compared to the control group 13, 14. These findings can be 
explained by the differences in the susceptibility to periodon-
titis between different subpopulations with type 1 DM, such 
as race, gender, etc. One of the important reasons supporting 
these findings can be the fact that the authors of the previous 
studies measured CAL, but not the total periodontitis-
affected teeth and sites. A significant correlation between the 
duration of the disease, its metabolic control and gingival in-
flammation presented by the relationship between bleeding 
and dental biofilm was found by analysing the relation of the 
clinical parameters of diabetes with the number of teeth af-
fected by periodontal infection (defined as any loss of epithe-
lial attachment level visible on minimum of two non-
adjacent teeth) 12. It indicates once again that in young pa-
tients with type 1 DM the duration of the disease and meta-
bolic control have an impact on the prevalence of gingival 
inflammation and progression toward periodontitis and that 
there is a higher risk of developing more severe forms of pe-
riodontitis 11, 12, 17, 30. Besides, the study of Foia et al. 31 clearly 
showed that children and adolescents are susceptible to de-
structive types of periodontitis, especially when the external 
etiological factors (microbial flora) are associated with diabe-
tes. These data can be interpreted by the lack of metabolic con-
trol which increases the risk of developing gingival inflamma-
tion and hinders the healing of the incurred damage. 
Diagnostic biomarkers of periodontitis and type 1 
diabetes mellitus 
An early detection of the disease has an important role 
in the success of therapy. If the disease is diagnosed earlier, 
the chances for a successful treatment are increased, or, if 
impossible, a better control of the disease course is enabled. 
In most cases, the diagnosis is established only after the de-
velopment of the first symptoms of the disease. Therefore, in 
order to increase the rate of early detection of diseases, re-
searchers are focused on identifying biomarkers which could 
indicate the presence of the disease prior to the manifestation 
of clinical symptoms 32. 
One of the trends in the development of early diagnosis 
of periodontitis is the development of disease monitoring 
mechanisms. Basic and regular clinical and radiolographic 
measurements are useful for the detection and the diagnosis 
of the disease, but nowadays disease markers in saliva are 
increasingly used as diagnostic tests for periodontitis 33. Sa-
liva is used primarely beacause it is an ultrafiltrate of plasma 
and a body fluid which can be collected easily and non-
invasively making it suitable for investigating biochemical 
parameters such as free oxygen radicals, lipid peroxidation 
products, such as malondialdehyde (MDA) and cytokines. 
Even so, the examinations of the composition of saliva in 
children with Type 1 DM are scarce. Aren et al. 18 were one 
of the few who examined the composition saliva and found 
that the saliva of children with Type 1 DM had a lower pH 
and buffering capacity, whereas the peroxidase activity and 
the glycose, magnesium and calcium levels were increased 
compared to healthy children. Besides this, a positive corre-
lation was demonstrated between the peroxidase activity of 
gingival exudates and the severity of gingival inflammation, 
as well as the periodontal pocket depth. Additionally, MDA 
level in saliva and plasma 34, 35 and cytokine level in the gin-
gival crevicular fluid 36 and in the serum 37 were statistically 
significantly increased in patients with DM and gingivitis or 
periodontitis compared to healthy individuals, so more atten-
tion has recently been directed to the analysis of saliva in di-
abetic patients. Various studies have demonstrated that the 
biological activity of cytokines can directly influence the de-
gree of periodontal destruction (epithelial attachment loss, 
destruction of collagen and alveolar bone resorption) 38, 39. 
The individual course of periodontitis indicates the impor-
tance of conducting complex researches of cytokines respon-
sible for the beginning, progression and/or suppression of the 
immune response 40. However, only a few studies have in-
vestigated local periodontal inflammation at the biochemical 
and immunological level in patients with DM. The latest 
findings suggest that hyperglycaemia can lead to the in-
creased production of inflammatory mediators, e.g. Enge-
bretson et al. 41 demonstrated that inadequate metabolic con-
trol was associated with an elevated level of interleukin-1β 
(IL-1β) in the gingival crevicular fluid. These data also indi-
cate the mechanism which explains the relationship between 
poor metabolic control and periodontal destruction. Hyper-
triglyceridemia, which is accompanied by DM, leads to an 
increased production of pro-inflammatory mediators in mo-
nocytes, such as tumor necrosis factor-α (TNF-α) and IL-1β, 
while neutrophils produce more IL-1β accompanied by the 
disorders of chemotaxis and phagocytosis. The increased 
level of pro-inflammatory mediators, which can be used for 
diagnostic purposes, was found not only in serum, but also in 
the gingival crevicular fluid of hyperlipidemic patients with 
type 2 DM 42, 43. 
It is assumed that patients with periodontitis can have 
increased levels of some circulating inflammatory markers. 
Periodontal monocytes, macrophages, fibroblasts and endo-
thelial cells respond to the microorganisms, lipopolysaccha-
rides and other antigens of the dental biofilm, and secrete 
numerous chemokines and inflammatory cytokines, prima-
rely TNF-α, prostaglandin E2 (PGE2) and interleukins (IL-
1β and IL-6), in the systemic circulation. Advanced glycation 
end products (AGE), accumulated in monocytes due to hy-
perglycemia, and their binding to their dedicated receptors 
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(RAGE) increases the oxidative stress in cells and activates 
the transcription nuclear factor-kappa B (NF-κB) which in-
fluences the phenotype of monocytes/macrophages and leads 
to the increased production of proinflammatory cytokines, 
such as IL-8 and TNF-α 44. This increased production of pro-
inflammatory cytokines is critical for the chronic inflamma-
tory processes in the formation of atheromatous lesions in 
large blood vessels 45, 46. Through the oxidative stress, DM 
affects the inflammatory processes in the gingiva by increas-
ing the accumulation of AGE-modified protein 47. The levels 
of IL-8, TNF-α and PGE2 in the gingival crevicular fluid are 
increased in patients with DM compared to healthy individu-
als due to the interaction between the AGE-modified protein 
and RAGE receptor in the periodontal tissues. 
IL-8 is a proinflammatory cytokine that plays a signifi-
cant role in the pathogenesis of periodontitis in patients with 
DM, especially in those with poor metabolic control. The 
study of Erbağci et al. 48 showed that the level of serum IL-8 
was significantly higher in children and adolescents with 
type 1 DM compared to the systemicaly healthy children 
while maintaining a correlation between age, weight, lipid 
status, apolipoproteins and glycaemic control. In the same 
group of subjects, the concentration of IL-8 in saliva was al-
so statistically much higher in children with type 1 DM 49. 
However, a statistically significant difference was not found 
when the level of IL-8 in the saliva of children with type 1 
DM and concomitant periodontitis was compared to children 
with only type 1 DM. This was the first examination of sali-
vary inflammatory mediators in children and adolescents 
with type 1 DM accompanied by periodontitis. Having in 
mind that the advanced periodontitis can cause an additional 
increase in the level of IL-8 in the saliva, the authors of this 
study determined the severity of periodontitis. The average 
PPD in children with type 1 DM and periodontitis was 2.05 
mm, while the average value of CAL was 1.31 mm, demon-
strating that periodontitis was in its initial phase. Considering 
that there was no correlation between the periodontal pa-
rameters and the level of IL-8 in saliva, the authors con-
cluded that the increased level of salivary IL-8 was caused 
by the presence of metabolic changes related to DM and not 
by periodontitis. The source of the elevated IL-8 level could 
be hyperglycaemia which can induce the transcription of IL-
8 gene in human endothelial cells 50. In addition, it was 
shown that hyperglycaemia and ketosis regulate the produc-
tion of IL-8 in cultivated monocytes 51. 
Besides IL-8, according to the results of Karlsson et 
al. 52, the level of interferon-γ (IFN-γ) in peripheral mononu-
clear cells in children and adolescents with type 1 DM with 
good and poor metabolic control was statistically much high-
er compared to the control group of healthy children and 
adolescents. According to the same authors’ data, the ele-
vated level of IFN-γ caused adaptation or improvement of 
the immune response to infection. Contrary to Karlsson et 
al. 52, a statistically significant increase in the level of IFN-γ 
was not found in the serum 48 and saliva 49 of patients with 
type 1 DM and periodontitis, although the level of IFN-γ in 
children with type 1 DM was 17% higher compared to 
healthy subjects. Considering that saliva is an ultrafiltrate of 
plasma, an increased serum level of IFN-γ was not reflected 
in the saliva, because it is a large molecule that probably 
could not pass easily through the capillary endothelium of 
the oral mucosa. Taking into account that IL-5 and IL-4 have 
some common characteristics in relation to the reduced in-
fection sensitivity, it is important that Karlsson et al. 52 found 
that patients with type 1 DM had a statistically significant in-
crease in the relationship of both markers to the IFN-γ level 
in blood. Accordingly, the results of Karlsson et al. 52 and 
Foss Freitas et al. 53 show that the favorable relationship be-
tween the increased levels of IFN-γ and IL-5 represents an 
adequate response of the immune system to an inflammatory 
process in the oral cavity (i.e. periodontitis). It should be 
stressed that another study showed that the large difference 
in the increase of the level of IL-5 compared to IFN-γ (4.8 
times) in the saliva was statistically much higher, and that 
the level of IL-5 in the saliva of children with type 1 DM 
was increased by 81.8% compared to the results of the con-
trol group 54. The increasing tendency draws attention sup-
ported by the assumption that the determination of the IL-5 
level may serve as one of the markers of the degree of in-
flammation. 
The development of molecular biology in clarifying in-
sulin resistance and dysfunction of β-cells has enabled the 
identification of the increased role of inflammatory media-
tors, especially cytokines and elements of the innate immune 
system in the pathogenesis of type 2 DM 55. The production 
of cytokines as a result of infection could potentially con-
tribute to the insulin resistance in numerous ways. In con-
trast, children and adolescents with type 1 DM depended 
solely on the exogenous insulin, whose rhythmic intake ef-
fects glucose metabolism in an uneven way. This is exactly 
the reason why the general condition of children and adoles-
cents was disrupted in the following years, and therefore at 
greater risk of developing a severe form of periodontitis. 
Thus, similar to adults, the parallelism can be expected be-
tween the severe form of periodontitis and a significant in-
crease in the levels of cytokines, which would hamper their 
dental care. 
Conclusion 
Type 1 diabetes mellitus is a significant etiopathogenic 
factor responsible for the development of diabetic periodon-
titis. This is confirmed by a statistically significant increase 
in the incidence and proinflammatory condition of the entire 
organism. Hyperglycaemia damages periodontal tissues 
through several mechanisms, primarily due to the damages 
of the mechanism of immune response, non-enzymatic gly-
cosylation and increased oxidative stress. 
In terms of a very high incidence of both diseases and 
their potentially serious repercussions, other medical special-
ists should have an important role in encouraging patients to 
visit their dentists regularly in order to control the etiological 
factors, especially the dental biofilm. Dentists should also 
bear in mind that the deterioration of glycolic metabolism 
and diabetes may deteriorate the condition of periodontitis. 
Contemporary literature on the treatment of children and 
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adolescents suffering from the aforementioned diseases empha-
sises the need for the regular application of the following analy-
sis and procedures: glycemic values, HbA1C and the most sig-
nificant biochemical parameters of DM, because hyperglycae-
mia has a negative impact on the anti-inflammatory response 
and increases the oxidative stress of microvascular disorder in 
periodontal tissues. It is essential to have a protocol for the 
treatment of periodontitis, which involves the local periodontal 
mechanical treatment as well as local and systemic medication 
treatment. The elimination of periodontal pathogens from the 
periodontal, pockets reduces the intensity of local inflammation, 
thus improving the overall condition of the body, because of the 
positive effect on the overall condition of glucose regulation.  
Besides that periodontitis has already been defined as the 
sixth complication of diabetes mellitus, the results of numerous 
studies imply that periodontitis is an inflammation with the pos-
sible systemic response and subsequent disorder of glucose 
regulation.  
In addition to the regular procedures in monitoring the 
condition and prognosis of diabetes and periodontitis, the analy-
ses of saliva and gingival crevicular fluid are also recommended 
as non-invasive and relatively reliable sources of information on 
the aforementioned diseases. Therefore, the cooperation be-
tween pediatric endocrinologists and dentists is required in order 
to preserve and improve the general health of children and ado-
lescents. 
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Findings of clinical studies which investigated the correlaton beetwen type 1 diabetes mellitus (DM)  
and periodontal disease 
Author/     
year 
Study popu-
lation  
 
Duration of 
diabetes  
mellitus Type 1 
(years) 
Glycated 
haemoglobin level – 
HbA1c (%)  
Gingival 
parameters  
Periodontal  
parameters  
Main findings   
Rylander 
et al.  
1987. 56 
46 patients 
with DM1 
mean age 
22.1 ± 4.7   
41 healthy 
individuals        
mean age 
22.3 ± 2.1      
10–14 years – 
24 children 
15–19 years – 
20 children  
> 20 years – 2 
children   
< 7.0 – 2 children 
7.0–8.9 – 13 children 
9.0–11.9 – 17 children 
12.0–13.9 – 12 children  
> 14.0 – 2   children 
PI   
GI  
PPD (mm) 
only probing 
depths of > 3 
mm  
CAL (mm) 
measured at 
4 sites 
around each 
tooth 
GR (mm)   
Higher frequency with clinical attachment loss on buc-
cal sites, and GR in diabetic group than in the control 
group. 
The presence of dental biofilm on these tooth surfaces 
was equally low in the 2 groups; in interproximal re-
gions 
very low frequency of periodontal tissue breakdown 
Rosenthal 
et al.  
1988.  57 
52 patients 
with DM1 
mean 14.5 
years   
NR Patients with DM1 
without 
periodontitis 
HbA1c – 12.56%  
DM1 patients with  
periodontitis 
HbA1c – 9.17%  
PI 
GI  
SBI          
PPD (mm) 
measured at 
4 sites 
around each 
tooth 
GI and SBI were significantly higher in the periodontitis 
group. PI was not significantly different between the 
groups. Diabetics with periodontitis had a significantly 
lower glycosylated hemoglobin than diabetics without 
periodontitis 
Sandholm 
et al.  
1989.  58   
 
85 patients 
with DM1  
mean 15.1 ± 
1.5 SV years     
85 healthy 
adolescents       
mean 15.1 ± 
1.6 years   
mean 5.2 ± 3.5 
years 
mean 10.9 ± 2.2 (SD) PI   
GI  
RC     
CPITN (reg-
istrated using 
16, 21, 26, 
36, 41 and 46 
as index 
teeth) 
PPD (mm) 
measured at 
4 sites 
around each 
tooth 
Finnish adolescents with DM1 had more gingivitis than 
their age- and sex-matched healthy controls. There were 
no differences in periodontal destruction as measured in 
number of pockets > 4 mm. All gingivitis does not lead 
to periodontitis, but periodontitis preceeded by gingivitis 
  
Pinson et 
al.   
1995. 14   
 
26 patients 
with DM1 
mean 13.50 ± 
3.36 years  
included one 
set of identi-
cal twins 
24 control 
subjects       
mean 13.54 ± 
3.08 years    
mean 6.58 ± 
3.66 years,  
with 24 of the 
patients having 
had DM1 for at 
least 5 years 
 
3.4–6.1 – 6  children 
6.2–9.0 – 9  children 
> 9.0 – 11 children 
 
PI   
GI 
gingival 
bleeding 
on probing   
PPD (mm) 
measured at 
4 sites of 
each tooth  
CAL (mm) 
measured at 
4 sites 
around each 
tooth  
GR (mm)   
Significant association of age with pocket probing 
depth, clinical attachment levels, and bleeding in the 
diabetic group. 
Duration of diabetics and metabolic control level were 
not related to periodontal parameters. 
DM1 had a significant association with severity of pe-
riodontitis when tooth sites in patients groups were sta-
tistically compared 
Kar-
jalainen et 
Knuuttila  
1996.  59 
12 patients 
with DM1 
mean 10.6 ± 
2.4 years    
80 healthy 
subjects     
mean 14.5 ± 
1.6 years    
NR on the 3rd day in hospi-
tal  
14.9 ± 3.8%   
on the 12rd day in hos-
pital  
13.1 ± 2.9%   
on the 1st outpatient 
visit at the hospital 1 
month later 
8.4 ± 1.5%  
PI  
% of visi-
ble plaque 
gingival 
bleeding 
on probing 
% of 
bleeding 
surfaces 
NR Hyperglycaemia and poor metabolic control of diabetes 
increased gingival bleeding. Not all gingivitis proceeds 
into a destructive periodontal disease.  Lower  resistance 
toward dental plaque in poorly-controled patients indi-
cates that  biological alterations could take place during 
glucose balance deterioration  
Firatli  
1997.  16   
 
77 patients 
with DM1 
mean age 
12.47 years  
 
77 healthy 
volunteers     
mean age 
12.59 years 
mean 48.34 ± 
23.69 months 
children with DM1 
9.34 ± 3.99%    
 
control group 
5.96 ± 1.02%    
PI  
GI  
gingival 
bleeding 
on probing 
PPD (mm) 
measured at 
4 sites of 
each tooth  
CAL (mm) 
measured at 
4 sites 
around each 
tooth 
A positive correlation between the duration  of  DM1 
and CAL. Relationship between the  duration of  DM1 
and severity of periodontal alterations 
Aren et al. 
2003.  18      
Group 1:   
16 newly di-
agnosed chil-
dren;    
mean age 
12.8 ± 5.8  
Group 2:   
16 children 
with diabetes 
of long dura-
tion;  
mean age 
12.7 ± 3.8  
Group 3: 
16 healthy 
Children in 
Group 1 with 
newly diag-
nosed DM1 
and 
Group 2 with 
diabetes of long 
duration;  
 
Group 1   
8.01 ± 1.79 % 
  
Group 2 
8.43 ± 1.36 % 
 
Group 3 
5.05 ± 0.36 % 
 
PI 
GI 
gingival 
bleeding 
on probing 
PPD (mm) Glycaemic status of the diabetic subjects affects the 
periodontal probing depths, salivary pH, buffering ca-
pacity, and peroxidase activity. 
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subjects; 
mean age 
12.4 ± 1.9  
 
Lalla et 
al. 
2006. 11 
182 patients 
with DM1  
mean 11.9 ± 
3.3 years   
160 healthy 
children   
mean 10.9 ± 
2.6 years      
mean 4.5 ± 8.0 
years  
 
Age of diagno-
sis DM1  
mean 7.8 ± 4.0 
years   
 
< 7.5% – 55 children 
7.5–9.5% – 80 children 
> 9.5% – 36 children  
PI  
% of sites 
PI  
GI  
% of  
bleeding 
sites  
GI score of  
2 or 3 de-
notes a 
bleeding 
site  
PPD (mm) 
measured at 
4 sites of 
each tooth  
CAL (mm) 
measured at 
4 sites 
around each 
tooth 
Number of 
affected teeth 
(at least one 
site with at-
tachment los  
> 2 mm on at 
least two 
teeth) 
Periodontal destruction was increased in children and 
adolescents with DM1. Diabetes started earlier in life 
than formerly recognized. 
Duration of DM1, and especially mean A1c, were not 
significantly correlated with the number of affected 
teeth.  
 
 
Lalla et 
al. 
2007.  17   
350 patients 
with DM1 
mean 11.33 ± 
3.41 years 
 
 
mean 3.96 ± 
3.39 years  
 
Age of diagno-
sis DM1  
mean 7.54 ± 4.0 
years    
< 7.5% – 97 children 
7.5–9.5% – 170 chil-
dren > 9.5% – 73 chil-
dren  
PI  
% of sites 
PI  
GI  
% of  
bleeding 
sites GI  
GI score of  
2 or 3 de-
notes a 
bleeding 
site 
PPD (mm) 
measured at 
4 sites of 
each tooth  
CAL (mm) 
measured at 
4 sites 
around each 
tooth 
Number of 
affected teeth 
(at least one 
site with at-
techment 
loss > 2 mm 
on at least 
two teeth) 
Increased periodontal destruction  in children and ado-
lescents with DM1 was connected with increased meta-
bolic control. 
If gingival bleeding and attachment loss measurements 
were both used, the present study revealed that hemo-
globin A1c significantly correlated with periodontitis   
Daković 
and  
Pavlović  
2008. 12 
 
187 patients 
with DM1 
mean 12.4 ± 
4.2 years 
178 healthy 
children     
mean 11.4 ± 
4.3 years     
mean 4.9 ± 3.5 
years  
 
Age of diagno-
sis DM1  
mean 7.9 ± 4.2 
years 
< 7.5% – 20 children 
7.5–9.5% – 95 children 
> 9.5% – 65 children 
PI 
 % of sites 
PI  
GI  
% of 
bleeding 
sites GI  
GBI 
bleed-
ing/plaque 
ratio  
PPD (mm) 
measured at 
4 sites of 
each tooth  
CAL (mm) 
measured at 
4 sites 
around each 
tooth 
Number (%) 
of patients 
with perio-
dontitis and 
any level of 
CAL, and 
CAL > 
1,5 mm 
   
Periodontal disease was more prevalent in children with 
DM1 and was in function of metabolic control and dis-
ease duration. The gingival inflammation in the evolu-
tion of periodontal destruction was more important in 
children with DM1 than in subjects without the disease 
Foia et al. 
2011. 31 
42 patients 
with DM1  
and periodon-
titis 
42 non-
diabetic sub-
jects 
with perio-
dontitis 
The subjects 
were divided 
into sub-
groups, ac-
cording to the 
age and 
metabolic 
control of 
DM1 
NR 
 
< 7%         – 22 chil-
dren          
 > 7%         – 20 chil-
dren           
PI  
GBI  
CAL (mm) 
measured at 
4 sites 
around each 
tooth 
All studies on clinical parameters reffering to periodon-
tal status in diabetic children were much higher than 
those in sistemically healthy group. Children were sus-
ceptible to periodontal destruction, especially when the 
etiologic external factors were associated with host re-
lated systemic impairment, such as insulin dependent 
diabetes.. Systemic diseased metabolic balance was sig-
nificantly conected with Gram-negative species-
mediated cytokine translocation from the periodontal 
space into the circulation.  
PI – plaque index; PPD  –  pocket probing depth; GR – gingival recession; GI – gingival index; CAL – clinical attachment level; NR – not reported; SBI – sulcus 
bleeding index; RCI – retentive calculus index; CPITN – community periodontal index of treatment needs; GBI –  gingival bleeding index. 
 
